Cargando…
Human somatic mutation assays as biomarkers of carcinogenesis.
This paper describes four assays that detect somatic gene mutations in humans: the hypoxanthine-guanine phosphoribosyl transferase assay, the glycophorin A assay, the HLA-A assay, and the sickle cell hemoglobin assay. Somatic gene mutation can be considered a biomarker of carcinogenesis, and assays...
Autores principales: | Compton, P J, Hooper, K, Smith, M T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1567966/ https://www.ncbi.nlm.nih.gov/pubmed/1954924 |
Ejemplares similares
-
Somatic cell gene mutations in humans: biomarkers for genotoxicity.
por: Albertini, R J, et al.
Publicado: (1993) -
Estimating the number of genetic mutations (hits) required for carcinogenesis based on the distribution of somatic mutations
por: Anandakrishnan, Ramu, et al.
Publicado: (2019) -
Are the Somatic Mutation and Tissue Organization Field Theories of Carcinogenesis Incompatible?
por: Rosenfeld, Simon
Publicado: (2013) -
Use of the glycophorin A human mutation assay to study workers exposed to styrene.
por: Compton-Quintana, P J, et al.
Publicado: (1993) -
Somatic mutation in PIK3CA is a late event in cervical carcinogenesis
por: Verlaat, Wina, et al.
Publicado: (2015)